Authors: Mengarelli, A Zarcone, D Caruso, R Tenca, C Rana, I Pinto, RM Grossi, CE De Rossi, G

Citation: A. Mengarelli et al., Adhesion molecule expression, clinical features and therapy outcome in childhood acute lymphoblastic leukemia, LEUK LYMPH, 40(5-6), 2001, pp. 625-630

Authors: Merlo, A Saverino, D Tenca, C Grossi, CE Bruno, S Ciccone, E

Citation: A. Merlo et al., CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4(+) T-cell clones specific for Mycobacterium tuberculosis, INFEC IMMUN, 69(10), 2001, pp. 6022-6029

Authors: Bruno, S Fabbi, M Tiso, M Santamaria, B Ghiotto, F Saverino, D Tenca, C Zarcone, D Ferrini, S Ciccone, E Grossi, CE

Citation: S. Bruno et al., Cell activation via CD44 occurs in advanced stages of squamous cell carcinogenesis, CARCINOGENE, 21(5), 2000, pp. 893-900

Authors: Saverino, D Fabbi, M Ghiotto, F Merlo, A Bruno, S Zarcone, D Tenca, C Tiso, M Santoro, G Anastasi, G Cosman, D Grossi, CE Ciccone, E

Citation: D. Saverino et al., The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions, J IMMUNOL, 165(7), 2000, pp. 3742-3755

Authors: Saverino, D Tenca, C Zarcone, D Merlo, A Megiovanni, AM Valle, MT Manca, F Grossi, CE Ciccone, E

Citation: D. Saverino et al., CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion, J IMMUNOL, 162(2), 1999, pp. 651-658

Authors: Zarcone, D De Rossi, G Tenca, C Marroni, P Mauro, FR Cerruti, GM Albi, N Fiorucci, S Velardi, A Grossi, CE

Citation: D. Zarcone et al., Functional and clinical relevance of CD44 variant isoform expression on B-celI chronic lymphocytic leukemia cells, HAEMATOLOG, 83(12), 1998, pp. 1088-1098